The biggest opportunity of the year...

It's finally that time of the year… Biotech conferences seem to make certain stocks surge like crazy for two months straight! But don't be mistaken — even though this profit window lasts for around 60 days… Individual biotech companies historically surge within the short period of time after they announce their developments! After ESPR presented data on a brand-new cholesterol-reducing ACL inhibitor… Their shares surged from $10 to nearly $80 right away! Disclaimer: Profits shown are not always typical. Bluebird Bio is another great example. After this gene-editing company told the public about their new drug Lenti-D… Their shares surged from around $50 to $230 over the next year! There could be dozens of similar opportunities in the days to come… And Lance Ippolito could help you get in on them! Get in now! New Money Crew A WealthPress Publication Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information. Brought to you by WealthPress.

Sent to: penunggangbadai.moneyblog@blogger.com

Unsubscribe

WealthPress, 15260 Hwy. 105 West, Suite 230-C, Montgomery, TX 77356, United States

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: